The Australian National University received all eight of the National Health and Medical Research Council’s recently announced ACT Project Grants, worth $3,195,000.

There is a lot of talk on how nanotechnology will soon be allowing us to build a wonderful array of nanomachines, from micron-sized motors to nanoscale train sets made from Teflon and cow’s brains.

Below is the proposal to the participants of the International Conference of Science & Technology Journalists (ICSTJ) in Tokyo, Japan, on the 26 October, 2001.

Genes that hop from one part of a living thing's DNA to another are helping to create medication to protect against group B meningitis, a form of the disease for which no vaccine yet exists.

A poison may in the future become the basis of vaccines used to treat or to protect against viral and auto-immune diseases and, eventually, some forms of cancer.

A fluorescent imaging system incorporating conventional endoscopy could lead to a new range of medical instruments capable of early detection of cancers.

Large-hearted Newfoundland dogs are being used to discover more about human heart disease. Dilated cardiomyopathy (DCM) is a heart ailment discovered in middle to old age in humans and in Newfoundland dogs aged four to eight years.

Television screens that can be rolled up for transport or storage, wallpapers and clothes whose pattern can be changed at will and faster internet connections are being developed by university researchers.

A $1 million Cray supercomputer will boost the research capabilities of Monash University's Engineering faculty.

CSIRO will provide funds for up to 60 post-graduate students around Australia, from 2002, in a program to encourage young science graduates to train for a career in research

Monash researchers hope to develop natural alternatives to existing anti-inflammatory drugs that could aid arthritis sufferers

Dr Greer, a senior research officer in the University of Queensland's Medicine Department at Royal Brisbane Hospital, has received a Foundation Research Excellence Award valued at $70,000.

Based in the School of Molecular and Microbial Sciences, University of Queensland, Dr Jennings and his team are analysing the structure and mechanisms of sugar-containing molecules in the bacteria which causes meningococcal meningitis (Neisseria meningitidis), in the hope of finding a viable vaccine target.

The coalition is set to review the policy that applies to external earnings of science agencies.

Steve Bracks, Victorian Premier, has just launched Gippsland's Ellinbank Institute, saying it would become Australia's leading dairy research facility following an $11.5 million redevelopment and expansion.